FINDINGS OF SCIENTIFIC MISCONDUCT

NIH GUIDE, Volume 24, Number 4, February 3, 1995



P.T. 34



Keywords:

  Ethics/Values in Science & Technol 

  Grants Administration/Policy+ 



Department of Health and Human Services



Notice is hereby given that the Office of Research Integrity (ORI)

has made final findings of scientific misconduct in the following

cases:



David F. Eierman, Ph.D., University of North Carolina at Chapel Hill:

The Division of Research Investigations (DRI) of the Office of

Research Integrity (ORI) reviewed an investigation conducted by the

University of North Carolina at Chapel Hill into possible scientific

misconduct on the part of Dr. Eierman while a research assistant at

the University of North Carolina.  Based in part on Dr. Eierman's

admission, the University concluded that he committed scientific

misconduct by falsifying or fabricating data in biomedical research

supported by two Public Health Service grants.  The ORI accepted the

University's conclusions and found that Dr. Eierman engaged in

scientific misconduct.



Dr. Eierman has fully cooperated with the University of North

Carolina and ORI in this matter and has signed a Voluntary Exclusion

Agreement under which he has agreed to be excluded from support under

Federal grants, contracts, and cooperative agreements for a three-

year period beginning December 12, 1994, and ending December 11,

1997, and from service on PHS advisory committees, boards, or peer

review groups for the same period.  ORI notes that Dr. Eierman's

cooperation in resolving this matter indicates that he has accepted

responsibility for his actions, and this is regarded as a positive

factor that was taken into consideration in negotiating the Voluntary

Exclusion Agreement.  The fabricated and falsified data were reported

in two manuscripts that were never published and in Figure 3 of "Beta

1 and Beta 2 Integrin Subunit Regulation of the Monocyte Inflammatory

Response," Cellular and Cytokine Networks in Tissue Immunity (M.

Meltzer, M. and A. Mantovani, Eds.). (1991). New York: Wiley-Liss.



Celia Ryan, R.N., University of Pittsburgh:  The Division of Research

Investigations (DRI) of the Office of Research Integrity (ORI)

reviewed an investigation conducted by the University of Pittsburgh

into possible scientific misconduct on the part of Ms. Ryan while an

employee of the University.  ORI concurred with the factual findings

as set forth in the University of Pittsburgh report, and finds that

Ms. Ryan committed scientific misconduct by falsifying and

fabricating interview data in a research project, "Assessment of the

Variation and Outcomes of Pneumonia," supported by a grant from the

Agency for Health Care Policy and Research, HS 06468.  Ms. Ryan

accepted the misconduct finding and agreed to a Voluntary Exclusion

and Settlement Agreement under which Ms. Ryan will not apply for, nor

permit her name to be used on any application for Federal grant or

contract funds, will not receive nor be supported by such funds, and

will not serve on PHS advisory committees, boards, or peer review

groups for a three-year period beginning January 11, 1995.



INQUIRIES



For further information, contact:



Director

Division of Research Investigations

Office of Research Integrity

5515 Security Lane, Suite 700

Rockville, MD  20852

Telephone:  (301) 443-5330



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)